Aurora Spine launched its SiLO TFX minimally invasive sacroiliac joint fixation system, the devicemaker said Sept. 13.
The system earned FDA clearance in October and made its debut in April. The system is designed for SI joint fusion when treating sacroiliac joint disruptions, degenerative sacroiliitis and other conditions. It has a Transfixing-Cone, an ilium screw, a sacrum screw and associated instruments.
“The release of SiLO TFX is proceeding smoothly and rapidly as we deploy more instruments sets and implants into the field,” Petra Lopizzo, Aurora Spine’s director of operations, said in the release.
Captiva Spine doubled its revenue year-over-year in the first quarter of 2025, largely due to accelerated market adoption of its…
Ten thousand patients have been treated with Augmedics’ Xvision augmented reality spine system, the company said April 22. The milestone…
The highest-paid CFO of orthopedic medtech companies in the U.S. saw more than $12 million per year in total compensation…
Comments are closed.